Siloton secures OCT product funding

Bristol-based start-up Siloton has secured £860,000 to support the commercial roll-out of its eye imaging chip technology which could help prevent blindness.

The funding package will enable the health technology company to advance its Akepa optical coherence tomography (OCT) chip technology and launch a research-specific version of the device in 2025.

Siloton’s technology aimed to make the diagnosis and monitoring of treatable retinal diseases more affordable and accessible, potentially saving the NHS over £1bn annually.

Dr Alasdair Price, CEO of Siloton, stated: ‘The population of individuals with retinal disease is growing. New, more affordable and accessible OCT systems like our Akepa technology will be critical to serving patients with precision and efficiency.’